Medicines composition for treating chronic heart failure and its prepn
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHIJIAZHUANG YILING PHARMA
- Publication Date
- 2003-03-19
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a pharmaceutical composition for treating chronic congestive heart failure, which belongs to the technical field of Chinese herbal medicine preparations, and is especially suitable for clinically treating heart disease of chronic congestive heart failure of Yang Qi deficiency, blood stasis and water stagnation, and can also be used for treating other types of heart failure. Background technique
[0002] Chronic congestive heart failure is mostly caused by the development and evolution of primary heart disease. It is a common critical illness in clinical practice. Blood flow is stagnant, blood stasis is blocked, "blood is unfavorable is water", and water and damp stop gathering, so patients with chronic heart failure often present with heart, lung, spleen, and kidney diseases, especially heart and kidney yang. Emptiness dominates. At present, there are mainly three types of western medicines used in the treatment of heart fail...